Mode
Text Size
Log in / Sign up
Phase 4 Completed N=343 Randomized Double-blind Treatment

PAIN - Postoperative Analgesia INvestigation

Source: ClinicalTrials.gov NCT02111746 ↗
Enrolled (actual)
343
Serious AEs
0.0%
Results posted
Oct 2018
Primary outcomePrimary: Postoperative Pain as Assessed by a Numeric Pain Scale (NPS) — 5.05; 5.02 units on a scale — p=0.934
◆ Published Evidence
Established
37citations · ~7 / year
Effectiveness of Standard Local Anesthetic Bupivacaine and Liposomal Bupivacaine for Postoperative Pain Control in Patients Undergoing Truncal Incisions: A Randomized Clinical Trial.
JAMA network open · 2021 · Open access · Likely link

Summary

The purpose of this study is to assess the efficacy of the intraoperative injection of prolonged acting (liposomal) bupivacaine in postoperative pain control after truncal surgical incisions.

Linked Publications

  • Effectiveness of Standard Local Anesthetic Bupivacaine and Liposomal Bupivacaine for Postoperative Pain Control in Patients Undergoing Truncal Incisions: A Randomized Clinical Trial.
    JAMA network open · 2021 · 37 citations · Open access · Likely link

Outcome Measures

OutcomeResultp-value
PRIMARY
Postoperative Pain as Assessed by a Numeric Pain Scale (NPS)
3.71; 3.03 0.014 sig
PRIMARY
Postoperative Pain as Assessed by a Five-point Satisfaction Scale
4.37; 4.37 1
PRIMARY
Postoperative Pain as Assessed by the Brief Pain Inventory (BPI)
4; 3.53 0.202
SECONDARY
Overall Opioid Use
SECONDARY
Mean Length of Hospital Stay
SECONDARY
Change From Baseline in Quality of Life
SECONDARY
Number of Participants Who Attain Physical Therapy Goal That Justifies Discharge From Inpatient Physical Therapy Within 72 Hours
SECONDARY
Hospital Cost for Patient Care During Hospitalization

Eligibility Criteria

Inclusion Criteria

  • 18 years-old or older, and
  • Sternotomy, thoracotomy, laparotomy or mini-thoracotomy incision is planned
  • There is reasonable expectation that the patient will be extubated within 24 hours after surgery

Exclusion Criteria

  • The patient has a known allergy to morphine or any opioid
  • The patient has a known chronic pain disorder or takes daily opioid medication > 1 month prior to surgery
  • There is anticipated difficulty communicating pain status due to language or other barriers at the investigator discretion
  • High postoperative morbidity index based on preoperative assessment, such as, low likelihood of extubation within 24 hours, extensive thoracoabdominal aortic aneurysm (Extent 2 TAAA), preoperative renal insufficiency/failure, etc.
View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT02111746) and the linked publication. Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.

Back to search